Copyright
©The Author(s) 2022.
World J Hepatol. Mar 27, 2022; 14(3): 570-582
Published online Mar 27, 2022. doi: 10.4254/wjh.v14.i3.570
Published online Mar 27, 2022. doi: 10.4254/wjh.v14.i3.570
Baseline sCr | A sCr value obtained in 3 mo prior to hospital admission, with preference to the value dated the closest to hospital admission. In patients without a previous sCr value, the value on admission should be used |
AKI definition | Increase in sCr ≥ 0.3 mg/dL (≥ 26.5 µmol/L) within 48 h; or the percentage increase in sCr ≥ 50%, which occurred in the last 7 d |
Stage 1 AKI | Increase in sCr ≥ 0.3 mg/dL (26.5 µmol/L) or an increase of 1.5 to 2 times the baseline value |
Stage 2 AKI | Increase of sCr 2 to 3 times the baseline value |
Stage 3 AKI | Increase in sCr > 3 times the baseline or sCr ≥ 4.0 mg/dL (353.6 µmol/L), with acute increase in sCr ≥ 0.3 mg/dL (26.5 µmol/L) or onset of RRT |
- Citation: Bredt LC, Peres LAB, Risso M, Barros LCAL. Risk factors and prediction of acute kidney injury after liver transplantation: Logistic regression and artificial neural network approaches . World J Hepatol 2022; 14(3): 570-582
- URL: https://www.wjgnet.com/1948-5182/full/v14/i3/570.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i3.570